Animal Models of Cognitive Impairment

Front Cover
Edward D. Levin, Jerry J. Buccafusco
CRC Press, Jun 22, 2006 - Medical - 400 pages
The costs associated with a drug's clinical trials are so significant that it has become necessary to validate both its safety and efficacy in animal models prior to the continued study of the drug in humans.

Featuring contributions from distinguished researchers in the field of cognitive therapy research, Animal Models of Cognitive Impairmen

 

Contents

1 Introduction
1
2 Muscarinic Receptor Antagonists in Rats
5
3 Nicotinic Receptor Antagonists in Rats
21
4 Involvement of the NMDA System in Learning and Memory
37
5 Animal Models and the Cognitive Effects of Ethanol
49
6 Animal Models of Cognitive Impairment Produced by Developmental Lead Exposure
73
Consequences Conditioning and Cortex
101
What Animal Models Have Told Us
147
10 Cognitive Impairment in Transgenic Mouse Models of Amyloid Deposition
183
11 Cholinergic Receptor Knockout Mice
199
12 Assessments of Cognitive Deficits in Mutant Mice
223
13 Cognitive Pharmacology in Aging Macaques
285
14 Cognitive Impairment following Traumatic Brain Injury
301
15 Cognitive Impairment Models Using Complementary Species
315
16 Cognition Models and Drug Discovery
343
Index
357

9 Modeling Cognitive Deficits Associated with Parkinsonism in the ChronicLowDose MPTPTreated Monkey
169

Other editions - View all

Common terms and phrases

About the author (2006)

Edward D. Levin, Jerry J. Buccafusco

Bibliographic information